Location: Home>> Staff>> Home Page of Lishu Zhao                                                                                                                                                         [中文]
		Soochow University, 199 Renai Road, Suzhou Industrial Park, 215123, Suzhou Email: zhaolishuemily[AT]126.com
	Curriculum Vitae
		Apr. 1995	born in Hunan Province
		2013 - 2018	Bachelor degree, Xiangya Medical College, Central South University
		2018 - 2021	Master in oncology, the Second Xiangya Hospital, Central South University
		2021 - Present	Postdoc, School of Radiation Medicine and Protection (SRMP), Soochow University;  Doctoral candidate majoring in oncology, Shanghai Pulmonary Hospital, Tongji University
	Research
		Focused on targeted therapy and immunotherapy of lung cancer, synthesis and application of the nuclear medicine probes
	Publications
		1.Update on lymphocyte-activation gene 3 (LAG-3) in cancers: from biological properties to clinical applications Lishu Zhao, Hao Wang, Kandi Xu, Xinyue Liu, Yayi He* Chin Med J (Engl), 2022, 135(10), 1203-1212. 2. Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers Chunhong Hu#, Lishu Zhao#, Wenliang Liu#, Songqing Fan, Junqi Liu, Yuxuan Liu, Xiaohan Liu, Long Shu, Xianling Liu, Ping Liu, Chao Deng, Zhenhua Qiu, Chen Chen, Yi Jiang, Qingchun Liang, Lingling Yang, Yang Shao, Qiongzhi He, Danlei Yu, Yue Zeng, Yizheng Li, Yue Pan, Sujuan Zhang, Shenghao Shi, Yurong Peng, Fang Wu* J Immunother Cancer, 2021, 9(12), e003773. 3. Human leukocyte antigen class II-based immune risk model for recurrence evaluation in stage I-III small cell lung cancer Peixin Chen#, Lishu Zhao#, Hao Wang, Liping Zhang, Wei Zhang, Jun Zhu, Jia Yu, Sha Zhao, Wei Li, Chenglong Sun, Chunyan Wu, Yayi He*, Caicun Zhou J Immunother Cancer, 2021, 9(8), e002554. 4. Lymphocyte activation gene-3 is associated with programmed death-ligand 1 and programmed cell death protein 1 in small cell lung cancer Hui Sun#, Jiawei Dai#, Lishu Zhao#, Jun Zhu, Hao Wang, Peixin Chen, Hui Lu*, Qiankun Chen*, Zhemin Zhang* Ann Transl Med, 2021, 9(18), 1468. 5. Multiple primary lung cancers: a new challenge in the era of precision medicine Lishu Zhao, Chaoyuan Liu, Guiyuan Xie, Fang Wu*, Chunhong Hu* Cancer Manag Res, 2020, 12, 10361-10375. 6. Impact of renin-angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: a retrospective observational study Yanjun Zhong#, Lishu Zhao#, Guobao Wu, Chunhong Hu, Chenfang Wu, Min Xu, Haiyun Dong, Quan Zhang, Guyi Wang, Bo Yu, Jianlei Lv, Chao Wu, Siye Zhang, Chenghui Cao, Long Shu, Yue Pan, Xianling Liu, Fang Wu* J Int Med Res, 2020, 48(12), 300060520979151.
		返回顶部